glp 1 insulin secretion Glucagon-like peptide (GLP-1) GLP-1 receptor signalling promotes β-cell

Our articles on Insulin Resistance Explained, Postprandial Glucose Dysregulation, and HOMA-IR and Insulin Resistance explore these connections in more detail

In addition, a study using LPS-exposed RAW264.7 macrophages and a DSS-triggered colitis murine model demonstrated that GLP-1 attenuates inflammatory responses by inhibiting the phosphorylation process of AKT/NF-B and MAPK signal-transducing molecules under in vitro and in vivo circumstances, respectively [219]

Victoza may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, severe GI side effects, hypersensitivity reactions, increased heart rate, abdominal pain, reflux, gas and dizziness

On average, people taking injectable weight loss drugs lose 5%-23% of their body weight

Available from: ScienceDirect Frontiers review: Du H, et al